Molecular Modeling Studies of Aldose Reductase Inhibitors

Yong S. Lee, Robert Pearlstein, Peter F. Kador

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Molecular modeling studies using the AM1 quantum chemical method and a torsional fitting method have been conducted on a series of aldose reductase inhibitors (ARIs) possessing an ionizable group and/or functional group susceptible to nucleophilic attack with the aim of defining the spatial position of ARI pharmacophores. AM1 quantum chemical calculations were conducted on ARIs possessing only an ionizable group to obtain their optimized geometries. These optimized structures were then superimposed on the model compound spirofluorene-9,5′-imidazolidine-2′,4′- dione (17). This superposition study suggests that a negative charge center residing in the vicinity of the 2′-oxygen of the imidazolidine-2′,4′-dione ring participates in the binding interactions. In addition, the optimized geometries of ARIs possessing both an ionizable group and an electronegative functional group were superimposed on spirofluorene-9,5′-imidazolidine-2′,4′-dione (17). The latter results also suggest the presence of a region where nucleophilic substitution can occur.

Original languageEnglish (US)
Pages (from-to)787-792
Number of pages6
JournalJournal of Medicinal Chemistry
Volume37
Issue number6
DOIs
StatePublished - Mar 1 1994

Fingerprint

Aldehyde Reductase
Oxygen
imidazolidine-2,4-dione

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Molecular Modeling Studies of Aldose Reductase Inhibitors. / Lee, Yong S.; Pearlstein, Robert; Kador, Peter F.

In: Journal of Medicinal Chemistry, Vol. 37, No. 6, 01.03.1994, p. 787-792.

Research output: Contribution to journalArticle

Lee, Yong S. ; Pearlstein, Robert ; Kador, Peter F. / Molecular Modeling Studies of Aldose Reductase Inhibitors. In: Journal of Medicinal Chemistry. 1994 ; Vol. 37, No. 6. pp. 787-792.
@article{000e4e2782444330ac98ddc11e9a2f2d,
title = "Molecular Modeling Studies of Aldose Reductase Inhibitors",
abstract = "Molecular modeling studies using the AM1 quantum chemical method and a torsional fitting method have been conducted on a series of aldose reductase inhibitors (ARIs) possessing an ionizable group and/or functional group susceptible to nucleophilic attack with the aim of defining the spatial position of ARI pharmacophores. AM1 quantum chemical calculations were conducted on ARIs possessing only an ionizable group to obtain their optimized geometries. These optimized structures were then superimposed on the model compound spirofluorene-9,5′-imidazolidine-2′,4′- dione (17). This superposition study suggests that a negative charge center residing in the vicinity of the 2′-oxygen of the imidazolidine-2′,4′-dione ring participates in the binding interactions. In addition, the optimized geometries of ARIs possessing both an ionizable group and an electronegative functional group were superimposed on spirofluorene-9,5′-imidazolidine-2′,4′-dione (17). The latter results also suggest the presence of a region where nucleophilic substitution can occur.",
author = "Lee, {Yong S.} and Robert Pearlstein and Kador, {Peter F.}",
year = "1994",
month = "3",
day = "1",
doi = "10.1021/jm00032a011",
language = "English (US)",
volume = "37",
pages = "787--792",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Molecular Modeling Studies of Aldose Reductase Inhibitors

AU - Lee, Yong S.

AU - Pearlstein, Robert

AU - Kador, Peter F.

PY - 1994/3/1

Y1 - 1994/3/1

N2 - Molecular modeling studies using the AM1 quantum chemical method and a torsional fitting method have been conducted on a series of aldose reductase inhibitors (ARIs) possessing an ionizable group and/or functional group susceptible to nucleophilic attack with the aim of defining the spatial position of ARI pharmacophores. AM1 quantum chemical calculations were conducted on ARIs possessing only an ionizable group to obtain their optimized geometries. These optimized structures were then superimposed on the model compound spirofluorene-9,5′-imidazolidine-2′,4′- dione (17). This superposition study suggests that a negative charge center residing in the vicinity of the 2′-oxygen of the imidazolidine-2′,4′-dione ring participates in the binding interactions. In addition, the optimized geometries of ARIs possessing both an ionizable group and an electronegative functional group were superimposed on spirofluorene-9,5′-imidazolidine-2′,4′-dione (17). The latter results also suggest the presence of a region where nucleophilic substitution can occur.

AB - Molecular modeling studies using the AM1 quantum chemical method and a torsional fitting method have been conducted on a series of aldose reductase inhibitors (ARIs) possessing an ionizable group and/or functional group susceptible to nucleophilic attack with the aim of defining the spatial position of ARI pharmacophores. AM1 quantum chemical calculations were conducted on ARIs possessing only an ionizable group to obtain their optimized geometries. These optimized structures were then superimposed on the model compound spirofluorene-9,5′-imidazolidine-2′,4′- dione (17). This superposition study suggests that a negative charge center residing in the vicinity of the 2′-oxygen of the imidazolidine-2′,4′-dione ring participates in the binding interactions. In addition, the optimized geometries of ARIs possessing both an ionizable group and an electronegative functional group were superimposed on spirofluorene-9,5′-imidazolidine-2′,4′-dione (17). The latter results also suggest the presence of a region where nucleophilic substitution can occur.

UR - http://www.scopus.com/inward/record.url?scp=0028219573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028219573&partnerID=8YFLogxK

U2 - 10.1021/jm00032a011

DO - 10.1021/jm00032a011

M3 - Article

C2 - 8145228

AN - SCOPUS:0028219573

VL - 37

SP - 787

EP - 792

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -